Callan Family Office LLC Purchases New Shares in UiPath, Inc. $PATH

Callan Family Office LLC purchased a new stake in UiPath, Inc. (NYSE:PATH - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 25,963 shares of the company's stock, valued at approximately $332,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. AdvisorNet Financial Inc raised its position in UiPath by 320.4% in the 2nd quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company's stock valued at $32,000 after buying an additional 1,887 shares during the last quarter. GAMMA Investing LLC increased its position in shares of UiPath by 48.0% during the 2nd quarter. GAMMA Investing LLC now owns 2,989 shares of the company's stock valued at $38,000 after purchasing an additional 969 shares during the last quarter. CX Institutional purchased a new stake in shares of UiPath during the 1st quarter valued at $36,000. Brooklyn Investment Group increased its position in shares of UiPath by 314.3% during the 1st quarter. Brooklyn Investment Group now owns 4,508 shares of the company's stock valued at $46,000 after purchasing an additional 3,420 shares during the last quarter. Finally, National Bank of Canada FI purchased a new stake in shares of UiPath during the 1st quarter valued at $72,000. 62.50% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on PATH shares. Wall Street Zen raised UiPath from a "buy" rating to a "strong-buy" rating in a research report on Saturday, September 6th. Needham & Company LLC reaffirmed a "hold" rating on shares of UiPath in a research report on Friday, September 5th. Truist Financial decreased their target price on UiPath from $13.00 to $12.00 and set a "hold" rating for the company in a research report on Friday, September 5th. Canaccord Genuity Group decreased their target price on UiPath from $16.00 to $15.00 and set a "buy" rating for the company in a research report on Monday, September 8th. Finally, DA Davidson started coverage on UiPath in a research report on Friday, September 5th. They set a "neutral" rating and a $12.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, twelve have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $13.21.

UiPath Stock Up 1.2%

Shares of NYSE PATH opened at $16.67 on Thursday. UiPath, Inc. has a 52 week low of $9.38 and a 52 week high of $18.74. The business has a 50-day simple moving average of $12.32 and a two-hundred day simple moving average of $12.14. The company has a market cap of $8.85 billion, a P/E ratio of 555.70, a P/E/G ratio of 6.10 and a beta of 1.07.

UiPath (NYSE:PATH - Get Free Report) last issued its earnings results on Thursday, September 4th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.08 by $0.07. UiPath had a return on equity of 1.28% and a net margin of 1.35%.The business had revenue of $361.73 million during the quarter, compared to the consensus estimate of $347.36 million. During the same quarter last year, the company earned $0.04 EPS. The firm's revenue was up 14.6% compared to the same quarter last year. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. Equities research analysts anticipate that UiPath, Inc. will post -0.17 EPS for the current year.

Insider Activity

In other news, CEO Daniel Dines sold 122,734 shares of UiPath stock in a transaction dated Wednesday, October 8th. The stock was sold at an average price of $14.89, for a total transaction of $1,827,509.26. Following the completion of the sale, the chief executive officer owned 613,670 shares in the company, valued at approximately $9,137,546.30. This trade represents a 16.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Ashim Gupta sold 240,874 shares of UiPath stock in a transaction dated Thursday, October 9th. The shares were sold at an average price of $17.28, for a total value of $4,162,302.72. Following the sale, the chief financial officer owned 696,117 shares of the company's stock, valued at approximately $12,028,901.76. This trade represents a 25.71% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 2,168,990 shares of company stock valued at $30,753,231. 23.19% of the stock is owned by corporate insiders.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.